🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/08/2011 | 30,01 | 30,73 | 29,92 | 30,48 | +2,01% | 2,70% | 23.822.298 |
| 22/08/2011 | 30,24 | 30,53 | 29,76 | 29,88 | +0,16% | 2,56% | 19.959.055 |
| 19/08/2011 | 29,38 | 30,02 | 29,34 | 29,83 | +0,64% | 2,31% | 21.733.634 |
| 18/08/2011 | 30,30 | 30,33 | 29,36 | 29,64 | -3,54% | 3,21% | 24.211.630 |
| 17/08/2011 | 30,90 | 31,05 | 30,41 | 30,73 | +0,31% | 2,07% | 14.691.178 |
| 16/08/2011 | 30,54 | 30,86 | 30,22 | 30,63 | -0,09% | 2,09% | 16.943.016 |
| 15/08/2011 | 30,20 | 30,69 | 30,01 | 30,66 | +2,52% | 2,24% | 19.320.509 |
| 12/08/2011 | 29,95 | 30,46 | 29,77 | 29,90 | +0,45% | 2,29% | 20.668.132 |
| 11/08/2011 | 28,43 | 30,11 | 28,38 | 29,77 | +4,66% | 6,08% | 31.264.774 |
| 10/08/2011 | 29,10 | 29,49 | 28,36 | 28,44 | -4,52% | 3,90% | 35.195.822 |
| 09/08/2011 | 29,01 | 29,81 | 28,12 | 29,79 | +4,28% | 5,82% | 38.925.445 |
| 08/08/2011 | 29,69 | 30,11 | 28,51 | 28,57 | -5,58% | 5,37% | 39.977.218 |
| 05/08/2011 | 30,31 | 30,53 | 29,34 | 30,26 | +0,63% | 3,93% | 31.972.698 |
| 04/08/2011 | 30,76 | 30,84 | 30,00 | 30,07 | -3,64% | 2,73% | 27.442.194 |
| 03/08/2011 | 31,39 | 31,71 | 30,73 | 31,20 | -0,61% | 3,13% | 23.115.002 |
| 02/08/2011 | 31,64 | 31,64 | 31,08 | 31,39 | -1,61% | 1,78% | 27.555.483 |
| 01/08/2011 | 32,68 | 32,72 | 31,30 | 31,91 | -2,02% | 4,35% | 26.725.048 |
| 29/07/2011 | 33,05 | 33,11 | 32,49 | 32,57 | -2,29% | 1,88% | 20.214.348 |
| 28/07/2011 | 33,65 | 33,73 | 33,29 | 33,33 | -0,74% | 1,30% | 14.503.796 |
| 27/07/2011 | 33,96 | 34,12 | 33,50 | 33,58 | -1,68% | 1,83% | 14.979.378 |
| 26/07/2011 | 34,27 | 34,36 | 34,02 | 34,15 | -0,28% | 1,00% | 10.009.762 |
| 25/07/2011 | 34,06 | 34,40 | 34,05 | 34,25 | -0,55% | 1,04% | 12.667.805 |
| 22/07/2011 | 34,63 | 34,79 | 34,29 | 34,44 | -0,25% | 1,43% | 7.946.250 |
| 21/07/2011 | 34,20 | 34,81 | 34,08 | 34,52 | +1,66% | 2,12% | 11.933.576 |
| 20/07/2011 | 34,25 | 34,25 | 33,89 | 33,96 | -0,56% | 1,03% | 8.728.058 |
| 19/07/2011 | 33,94 | 34,28 | 33,69 | 34,15 | +0,85% | 1,74% | 11.879.918 |
| 18/07/2011 | 34,05 | 34,17 | 33,69 | 33,86 | -1,22% | 1,40% | 11.136.782 |
| 15/07/2011 | 34,67 | 34,77 | 34,05 | 34,28 | -1,05% | 2,09% | 15.304.678 |
| 14/07/2011 | 34,51 | 34,89 | 34,37 | 34,65 | +0,78% | 1,49% | 16.066.888 |
| 13/07/2011 | 34,06 | 34,80 | 34,00 | 34,38 | +1,12% | 2,35% | 14.150.201 |